Avacta signals further growth in 2010
Avacta, the Science City York company whose technology is changing the world of medical diagnosis, has given a strong trading update and is on target to grow further in 2010.
Avacta operates through two divisions - Avacta Analytical, which develops and commercialises world-leading analytical products and provides specialised analytical services to the drug development sector; and Avacta Animal Health, which develops and markets diagnostic and rapid point-of-care testing products and services to vets.
Avacta recently acquired Reactivlab, expanding the range of veterinary diagnostic tests delivered by Avacta Animal Health. Strong sales are now expected of these tests, marketed as a laboratory service, in kit form and on the Midas point-of-care platform.
Prof Alastair Smith, Avacta’s chief executive, said: 'Avacta’s two divisions are growing strongly. Our two flagship products, Optim and Midas, will be key drivers of our growth in 2010 and beyond, delivering our strategy of commercialising our own innovative technologies and accelerating this growth through further acquisitions.'
Comments
Login
